Jane Street’s Indaptus Therapeutics INDP Stock Holding History

Jane Street’s Portfolio INDP Stock Details INDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-18	Closed	-$11K	–	7507
2020 Q2	$11K	Buy	+18	New	+$11.1K	﹤0.01%	6990
2018 Q3	–	Sell	-12	Closed	-$120K	–	5392
2018 Q2	$120K	Sell	12 -1	-8%	-$11.1K	﹤0.01%	4702
2018 Q1	$185K	Buy	+13	New	+$184K	﹤0.01%	4484
2015 Q4	–	Sell	-15	Closed	-$194K	–	4207
2015 Q3	$194K	Buy	+15	New	+$197K	﹤0.01%	3203

Other funds holding INDP

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

IWC

Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Jane Street's INDP Position: Q3 2020 in Review

Jane Street sold out of Indaptus Therapeutics (INDP) in Q3 2020, closing a stake of 18 shares — an estimated $11K sold.

Jane Street first reported a position in INDP in Q3 2015 and held it in 4 quarters. The position peaked at $194K in Q3 2015. 24 funds tracked by Wall St. Rank hold INDP as of Q3 2020.

Jane Street reported no remaining Indaptus Therapeutics position as of Q3 2020 after selling out during the quarter.
Jane Street sold 18 Indaptus Therapeutics shares in Q3 2020, an estimated $11K.
Jane Street first reported a position in Indaptus Therapeutics in Q3 2015 and held it in 4 quarters.
Jane Street's Indaptus Therapeutics position peaked at $194K in Q3 2015.
24 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q3 2020.

Based on Jane Street's 13F filing for Q3 2020, filed 17 Nov 2020.